Isoniazid prophylaxis in lung transplantation

Journal of Heart and Lung Transplantation

Volumn 19, Issue 9, 2000, Pages 903-906

  Roman, Antonio ^a   Bravo, Carles ^a   Levy, Gur ^a   Monforte, Victor ^a   Vidal, Rafael ^a   Solé, Joan ^a   Maestre, José ^a   Morell, Ferran ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; DRUG SAFETY; ENDEMIC DISEASE; FEMALE; HUMAN; INCIDENCE; LUNG TRANSPLANTATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; HUMAN; HYPERSENSITIVITY, DELAYED; ISONIAZID; LUNG TRANSPLANTATION; MIDDLE AGE; PROSPECTIVE STUDIES; TUBERCULOSIS, PULMONARY;

EID: 0033801537     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)00163-7     Document Type: Article

References (14)

1. Hosenpud J.D., Novick R.J., Bennett L.E., Keck B.M., Fiol B., Daily O.P. The registry of the International Society for Heart and Lung Transplantation thirteenth official report - 1996 . J Heart Lung Transplant. 15:1996;655-674.
2. Carlsen S.E., Bergin C.J. Reactivation of tuberculosis in a donor lung after transplantation. AJR Am J Roentgenol. 154:1990;495-497.
3. Ridgeway A.L., Warner G.S., Phillips P., et al. Transmission of mycobacterium tuberculosis to recipients of single lung transplants from the same donor. Am J Respir Crit Care Med. 153:1996;1166-1168.
4. Miller R.A., Lanza L.A., Kline J.N., Geist L.J. Mycobacterium tuberculosis in lung transplant recipients. Am J Respir Crit Care Med. 152:1995;374-376.
5. Schulman S.L., Scully B., McGregor C.C., Austin J.H.M. Pulmonary tuberculosis after transplantation. Chest. 111:1997;1459-1462.
6. Dromer C., Nashef S.A.M., Velly J.F., Martigne C.H., Couraud L. Tuberculosis in transplanted lungs. J Heart Lung Transplant. 12:1993;924-927.
7. Higenbottam T., Stewart S., Penketh A., Wallwork J. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation. 46:1988;532-539.
8. Moreno S., Baraia-Etxaburu J., Bouza E., et al. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med. 119:1993;194-198.
9. Rey R., Ausina V., Casal M., et al. Situación actual de la tuberculosis en España. Una prespectiva sanitaria en precario respecto a los países desarrollados. Med Clin (Barc). 105:1995;703-707.
10. Orriols R., Morell F., Curull V., Roman A., Sampol G. Impaired non-specific delayed cutaneous hypersensitivity in bird fanciers lung. Thorax. 44:1989;132-135.
11. Orriols R., Morell F., Fité E., et al. Reactividad cutánea retardada en una población de 400 pacientes hospitalizados. Estudio control. Med Clin (Barc). 77:1981;240-242.
12. Centers for Disease Control. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR Morb Mortal Wkly Rep 1991;40(Suppl RR-5):27-32.
13. John G.T., Thomas P.P., Thomas M., Jeyaseelan L., Jacob C.K., Shastry J.C.M. A double-blind randomized controlled trial of primary isoniazid prophylaxix in dialysis and transplant patients. Transplantation. 57:1994;1683-1684.
14. Grupo de Trabajo T.I.R. Quimioprofilaxis antituberculosa. Recomendaciones SEPAR. Arch Bronconeumol. 28:1992;270-278.